Blog

The landscape of effectively dealing with infectious diseases is continually changing. Learn about new topics and emerging trends around the world as clinicians try to improve patient outcomes and overall population health.

Article
July 18, 2022

Summer Travel 2022 – We’re Still in a Pandemic

In the best of times, summer travel can be a challenge, but for summer 2022, travel may be a bit more chaotic as the COVID-19 pandemic moves through unpredictable ups…
Article
June 15, 2022

Sexually Transmitted Infections and Disease: the Silent Pandemic

Twenty-five years ago, the Institute of Medicine (IOM) published a report on confronting sexually transmitted diseases (STDs) as the “hidden epidemic of tremendous health and economic consequence in the United…
Article
May 13, 2022

COVID-19: It’s Not Over Yet

It’s hard to believe that it’s been more than 2 years since the World Health Organization (WHO) declared COVID-19 a global pandemic on March 11, 2020. At that time, the…
Article
March 16, 2022

COVID-19 Testing for Travel—What Your Patients Need to Know

Whether upcoming travel is for relaxation, business, or a combination of both, testing for COVID-19 is likely an integral part of the trip, especially when traveling by air. There are…
Article
February 22, 2022

Omicron and COVID-19 testing: What healthcare providers need to know

As the SARS-CoV-2 omicron variant (B.1.1.529) rapidly became the dominant strain in South Africa in late 2021, public health officials around the globe recognized that a new, highly transmissible form…
Article
February 7, 2022

What is the difference between NAAT and PCR?

While the COVID-19 pandemic has brought phrases like “PCR test” and “antigen test” into wider use, one term that hasn’t been talked about as much is “NAAT,” which is short…
News
December 7, 2021

The Talis One™ COVID-19 Test System is expected to accurately detect the new coronavirus variant Omicron

Talis conducted a comprehensive in silico assessment comparing the Omicron (B1.1.529) variant published sequences from the GISAID database to its Talis One COVID-19 Test System. The bioinformatics analysis concluded that…
Article
October 20, 2021

3 Lessons from the emergence of the SARS-CoV-2 Delta variant

The emergence of the SARS-CoV-2 Delta variant highlights the importance of widespread vaccination and the ongoing need for accurate testing. New variants can quickly change the public health situation Positive…
Article
October 19, 2021

Addressing Healthcare disparities in the US with Point-of-Care Testing

Healthcare disparities in the US have become strikingly apparent throughout the COVID-19 pandemic, affecting historically underserved populations (e.g., lower-income households, Black and Minority Americans, immigrants, people with disabilities, rural populations,…

Join Our Newsletter

Subscribe to our newsletter for information about our products and company updates.


    TALIS BIOMEDICAL

    The GenBody COVID-19 Ag Test and the Talis One COVID-19 Test System are for use under Emergency Use Authorization (EUA) only. For In Vitro Diagnostic (IVD) use. For prescription use only. Talis is an authorized distributor of the GenBody COVID-19 Ag test.

    © Talis and Talis One are trademarks of Talis Biomedical Corporation. All Rights Reserved.

    *Additional testing solutions are currently in development and not available for sale.

    Disclaimer: Blog articles are presented for educational purposes only and are not intended to promote any Talis product or service. Opinions and conclusions are those of the respective authors.